Company Data

Elevation Oncology Inc.

Ticker
ELEV
Current Price
$0.6074 -6.53%
Market Cap
$35.9M
Price Target
Refer to Report
Volume
911.1K
52wk Range
$0.5 - $5.8299
Advanced Market Data

Overview

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy